Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zein Assad

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Lancet. Child & Adolescent Health|May 10, 2026
Effectiveness of nirsevimab immunisation after birth versus RSVpreF maternal vaccination in preventing RSV-related hospitalisations in infants: a population-based retrospective cohort studyZaba Valtuille, Inès Fafi, Florentia Kaguelidou, et al.
The New England Journal of Medicine|July 10, 2024
Nirsevimab and Hospitalization for RSV BronchiolitisZein Assad, Anne-Sophie Romain, Camille Aupiais, et al.
The Journal of Pediatrics|November 23, 2024
Surge of Pediatric Respiratory Tract Infections after the COVID-19 Pandemic and the Concept of "Immune Debt"Lea Lenglart, Luigi Titomanlio, Zsolt Bognar, et al.
The Lancet Regional Health. Europe|November 12, 2025
Effectiveness of nirsevimab against hospitalisation for RSV-bronchiolitis during high RSV-B circulation in the second year of nationwide implementation in France: a test-negative case-control studyApolline Furgier, Camille Brehin, Corinne Levy, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Lancet. Child & Adolescent Health|May 10, 2026
Effectiveness of nirsevimab immunisation after birth versus RSVpreF maternal vaccination in preventing RSV-related hospitalisations in infants: a population-based retrospective cohort studyZaba Valtuille, Inès Fafi, Florentia Kaguelidou, et al.
The New England Journal of Medicine|July 10, 2024
Nirsevimab and Hospitalization for RSV BronchiolitisZein Assad, Anne-Sophie Romain, Camille Aupiais, et al.
The Journal of Pediatrics|November 23, 2024
Surge of Pediatric Respiratory Tract Infections after the COVID-19 Pandemic and the Concept of "Immune Debt"Lea Lenglart, Luigi Titomanlio, Zsolt Bognar, et al.
The Lancet Regional Health. Europe|November 12, 2025
Effectiveness of nirsevimab against hospitalisation for RSV-bronchiolitis during high RSV-B circulation in the second year of nationwide implementation in France: a test-negative case-control studyApolline Furgier, Camille Brehin, Corinne Levy, et al.
Pageof 3